
Immunexpress Inc.
Get Full AccessDescription
- Immunexpress is a privately owned company creating revolutionary molecular diagnostics for sepsis. The company has offices in Seattle, USA and Brisbane, Australia. Immunexpress's product pipeline aims to address the overwhelming unmet clinical needs of sepsis patients, as well as clinicians, payers and healthcare systems.Unlike the traditional approach to sepsis diagnosis, SeptiCyte® quantifies the specific molecular biomarkers from a patient's immune system ('host response'). Biomarkers capture signals from a patient's immune system in response to infection. These biomarkers may hold the key to early detection of sepsis, as well as guiding the use and timing of drugs and other therapies.
-
Headquarters:425 Pontius Avenue North Suite 430, Seattle, Washington, United States
More -
Phone Number: +1 206-858-6436
-
Website: http://www.immunexpress.com
-
Employees:14
-
Revenue:$10 - 50M
-
Legal Name:Immunexpress Inc.
-
Immunexpress Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Frequently Asked Questions regarding Immunexpress Inc.
-
Where are Immunexpress Inc.'s Headquarters?
Immunexpress Inc.'s Headquarters are in 425 Pontius Avenue North Suite 430,Seattle,Washington,United States
-
What is Immunexpress Inc.'s phone number?
Immunexpress Inc.'s phone number is +1 206-858-6436
-
What is Immunexpress Inc.'s official website?
Immunexpress Inc.'s official website is http://www.immunexpress.com
-
What is Immunexpress Inc.'s Revenue?
Immunexpress Inc.'s revenue is $10 - 50M
-
What is Immunexpress Inc.'s NAICS code?
Immunexpress Inc.'s NAICS code is 541713
-
How many employees are working in Immunexpress Inc.
Immunexpress Inc. has 14 employees
-
What is Immunexpress Inc.'s Industry?
Immunexpress Inc. is in the industry of Biotechnology
-
Who is Immunexpress Inc.'s Chief Medical Officer?
Immunexpress Inc.'s Chief Medical Officer is Roy Davis